Major challenges in the global amyotrophic lateral sclerosis treatment market

The global amyotrophic lateral sclerosis treatment market is expected to grow at a CAGR of 19.85% during the forecast period. Major challenges hindering the growth of the global amyotrophic lateral sclerosis treatment market include patent expiry of drugs, high cost of treatment, and availability of ineffective diagnosis methods.

Amyotrophic lateral sclerosis may be difficult to diagnose accurately because the initial symptoms of amyotrophic lateral sclerosis are similar to those seen in other neurological diseases. Direct diagnostic tests are not available to determine the presence of amyotrophic lateral sclerosis in individuals. Instead, physicians opt to perform a series of tests, which help to distinguish amyotrophic lateral sclerosis from similar neurological diseases to arrive at an accurate diagnosis for amyotrophic lateral sclerosis.

Request for: Free Sample Report

According to the Amyotrophic Lateral Sclerosis Therapy Development Institute, healthcare professionals assess physical symptoms and take simple blood and urine tests at the time of disease progression. Electromyography and nerve conduction studies are also done to eliminate possibilities of comorbidities or other neurological disorders. Initial symptoms of amyotrophic lateral sclerosis and multiple sclerosis are similar and may include muscle weakness, loss of coordination, and difficulty in moving limbs. Hence, the availability of ineffective diagnosis methods is expected to limit the growth of the market. However, despite the challenges, the global amyotrophic lateral sclerosis treatment market is expected to grow in an accelerating momentum during the forecast period.